IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+16.12%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$181M
AUM Growth
+$181M
(+13%)
Cap. Flow
+$1.9M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
47.21%
Holding
67
New
10
Increased
16
Reduced
17
Closed
11
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.4M |
| 2 |
SHPG
Shire pic
SHPG
|
$4.25M |
| 3 |
CELG
Celgene Corp
CELG
|
$3.92M |
| 4 |
Sanofi
SNY
|
$3.88M |
| 5 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$3.58M |
Top Sells
| 1 |
Amgen
AMGN
|
$7.41M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$3.3M |
| 3 |
AbbVie
ABBV
|
$3.27M |
| 4 |
Zimmer Biomet
ZBH
|
$2.84M |
| 5 |
DexCom
DXCM
|
$2.6M |
Sector Composition
| 1 | Healthcare | 80.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.78B
| $2.93M | 1.42% |
50,000
-10,000
| -17% | -$586K |
|
|
NVDQ
27
DELISTED
Novadaq Technologies Inc.
NVDQ
| $2.91M | 1.41% |
175,000
+50,000
| +40% | +$831K |
|
|
28
Zimmer Biomet
ZBH
$21B
| $2.84M | 1.37% |
25,000
-25,000
| -50% | -$2.84M |
|
|
HZNP
29
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.58M | 1.25% |
200,000
-20,000
| -9% | -$258K |
|
|
DYAX
30
DELISTED
DYAX CORPORATION
DYAX
| $2.46M | 1.19% |
175,000
-10,000
| -5% | -$141K |
|
31
Pfizer
PFE
$141B
| $2.34M | 1.13% |
+75,000
| New | +$2.34M |
|
32
Ultragenyx Pharmaceutical
RARE
$2.89B
| $2.19M | 1.06% |
50,000
-7,500
| -13% | -$329K |
|
33
QuidelOrtho
QDEL
$1.95B
| $2.17M | 1.05% |
+75,000
| New | +$2.17M |
|
34
OraSure Technologies
OSUR
$242M
| $2.03M | 0.98% |
200,000
+25,000
| +14% | +$254K |
|
35
Puma Biotechnology
PBYI
$254M
| $1.89M | 0.91% |
10,000
| – | – |
|
36
Celldex Therapeutics
CLDX
$1.47B
| $1.83M | 0.88% |
100,000
-50,000
| -33% | -$913K |
|
|
SPNC
37
DELISTED
Spectranetics Corp
SPNC
| $1.73M | 0.84% |
50,000
-65,000
| -57% | -$2.25M |
|
|
ELOS
38
DELISTED
Syneron Medical Ltd
ELOS
| $1.63M | 0.79% |
175,000
+55,000
| +46% | +$513K |
|
|
FLXN
39
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.51M | 0.73% |
75,000
+25,000
| +50% | +$505K |
|
|
RAD
40
DELISTED
Rite Aid Corporation
RAD
| $1.5M | 0.73% |
+200,000
| New | +$1.5M |
|
|
CBAY
41
DELISTED
Cymabay Therapeutics
CBAY
| $1.23M | 0.59% |
125,000
| – | – |
|
42
MEI Pharma
MEIP
$160M
| $1.07M | 0.52% |
+250,000
| New | +$1.07M |
|
|
AXDX
43
DELISTED
Accelerate Diagnostics
AXDX
| $960K | 0.46% |
+50,000
| New | +$960K |
|
|
ACHN
44
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $919K | 0.44% |
+75,000
| New | +$919K |
|
45
BioCryst Pharmaceuticals
BCRX
$1.74B
| $912K | 0.44% |
+75,000
| New | +$912K |
|
|
DERM
46
DELISTED
Dermira, Inc.
DERM
| $906K | 0.44% |
+50,000
| New | +$906K |
|
47
Assembly Biosciences
ASMB
$190M
| $393K | 0.19% |
50,000
| – | – |
|
|
ELGX
48
DELISTED
Endologix Inc
ELGX
| $382K | 0.18% |
25,000
-157,500
| -86% | -$2.41M |
|
49
Agios Pharmaceuticals
AGIO
$2.19B
| – | – |
0
| – | – |
|
50
Arrowhead Research
ARWR
$3.05B
| – | – |
-90,000
| Closed | -$1.33M |
|